Showing 1,401 - 1,420 results of 64,888 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((mg decrease) OR (we decrease)) ))', query time: 1.25s Refine Results
  1. 1401
  2. 1402
  3. 1403
  4. 1404
  5. 1405
  6. 1406
  7. 1407
  8. 1408

    DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

    Published 2021
    “…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
  9. 1409
  10. 1410
  11. 1411

    Dehydrozingerone Improves Mood and Memory in Diabetic Mice via Modulating Core Neuroimmune Genes and Their Associated Proteins by Anuradha Kesharwani (21386000)

    Published 2025
    “…Additionally, anomalies in the glutamine-glutamate/GABA cycle could exacerbate diabetes-related cognitive deficits. Treatment with DH had a variety of advantages, including decreased neuroinflammation and neuronal cell death as well as the promotion of critical genes and proteins necessary to promote cognitive performance. …”
  12. 1412
  13. 1413
  14. 1414

    In we present the number of modules determined by DMSP on various values of connectivity density by Ioannis A Maraziotis (86282)

    Published 2011
    “…In figure we display the initial size of the kernel, as well as the final size of the module, for modules with various sizes, and densities above 0.5. …”
  15. 1415
  16. 1416
  17. 1417

    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs by Olivier Reynard (354756)

    Published 2016
    “…Compared to control animals treated with IgGs from non-immunized double KO pigs, the anti-EBOV IgGs-treated animals exhibited a significantly prolonged survival and a decreased virus load in blood on day 3. The data obtained indicated that IgGs lacking α1–3 Galactose and Neu5Gc, two highly immunogenic epitopes in humans, have a protective effect upon EBOV infection.…”
  18. 1418
  19. 1419
  20. 1420